Search Within

Arnab Ghosh

Formats
  1. Meeting Abstract (35)
  2. Journal Article (28)
  3. Review (1)
Groups
  1. Department of Medicine (64)
  2. Hematologic Malignancies, Division of (64)
  3. Weinberg Fellows (64)
  4. Center for Hematologic Malignancies (53)
  5. GSK Faculty (53)
  6. Executive Committee, Center for Hematologic Malignancies (43)

More Groups

People
  1. Marcel Van Den Brink (35)
  2. Amanda Holland (29)
  3. Robert Jenq (27)
  4. Odette Smith (25)
  5. Taha Merghoub (18)
  6. Uttam Rao (18)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (1)
  4. 2022 (4)
  5. 2021 (3)
  6. 2020 (8)

More Years

Publications
  1. Blood (13)
  2. Biology of Blood and Marrow Transplantation (9)
  3. Cancer Research (5)
  4. Journal of Clinical Investigation (4)
  5. Bone Marrow Transplantation (3)
  6. Journal for ImmunoTherapy of Cancer (3)

More Publications

Publishers
  1. American Society of Hematology (13)
  2. Elsevier Inc. (10)
  3. Nature Publishing Group (9)
  4. American Association for Cancer Research (6)
  5. American Society for Clinical Investigation (4)
  6. Biomed Central Ltd (4)

More Publishers

Results (64)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Pourpe, S.; Ghosh, A.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • CTLA-4 blockade promotes Treg glucose metabolism and reduces Treg functional stability in glycolysis-defective tumors
    Meeting Abstract

    Zappasodi, R.; Serganova, I.; Cohen, I.; Maeda, M.; Senbabaoglu, Y.; Shindo, M.; Maniyar, R.; Mane, M.; Leftin, A.; Watson, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Heteroclitic peptide cancer vaccine counters MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J. J.; Pourpe, S.; Ghosh, A.; Bozkus, C. C.; Mangarin, L. M. B.; Redmond, D.; Verma, S.; Schad, S.; more...
    Journal of Immunology (2020)

    Fulltext@MSK | Save
  • CTLA-4 blockade drives loss of regulatory T cell functional stability in glycolysis defective tumors
    Meeting Abstract

    Zappasodi, R.; Serganova, I.; Cohen, I.; Maeda, M.; Shindo, M.; Senbabaoglu, Y.; Leftin, A.; Maniyar, R.; Verma, S.; Lubin, M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Prognostic factors for postrelapse survival after ex vivo CD34(+)-selected (T cell-depleted) allogeneic hematopoietic cell transplantation in multiple myeloma
    Journal Article

    Gomez-Arteaga, A.; Shah, G. L.; Baser, R. E.; Scordo, M.; Ruiz, J. D.; Bryant, A.; Dahi, P. B.; Ghosh, A.; Lahoud, O. B.; Landau, H. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Fraction genome altered (FGA) to regulate both cell autonomous and non-cell autonomous functions in prostate cancer and its effect on prostate cancer aggressiveness
    Meeting Abstract

    Chakraborty, G.; Ghosh, A.; Nandakumar, S.; Armenia, J.; Mazzu, Y. Z.; Atiq, M. O.; Lee, G. S. M.; Mucci, L. A.; Merghoub, T.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Time to relapse and the patterns of relapse are prognostic for post-relapse survival after CD34(+)-selected allogeneic hematopoietic stem cell transplantation in multiple myeloma
    Meeting Abstract

    Gomez-Arteaga, A.; Shah, G. L.; Baser, R. E.; Ruiz, J. D.; Bryant, A.; Chung, D. J.; Dahi, P. B.; Ghosh, A.; Lahoud, O. B.; Landau, H. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Checkpoint inhibitors in AML: Are we there yet?
    Review

    Ghosh, A.; Barba, P.; Perales, M. A.
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Chimeric antigen receptor-induced BCL11B suppression propagates NK-like cell development
    Journal Article

    Maluski, M.; Ghosh, A.; Herbst, J.; Scholl, V.; Baumann, R.; Huehn, J.; Geffers, R.; Meyer, J.; Maul, H.; Eiz-Vesper, B.; more...
    Journal of Clinical Investigation (2019)

    Fulltext@MSK | Save
  • TP53-stabilization with APR-246 enhances antitumor effects of immune checkpoint in preclinical models
    Meeting Abstract

    Ghosh, A.; Michel, J.; Dong, L.; Suek, N.; Zhong, H.; Budhu, S.; de Henau, O.; Wolchok, J.; Merghoub, T.
    Cancer Research (2019)

    Fulltext@MSK | Save